Literature DB >> 23836187

Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment.

Edward Sionov1, Yun C Chang, Kyung J Kwon-Chung.   

Abstract

We have previously reported that Cryptococcus neoformans strains are innately heteroresistant to fluconazole in vitro, producing minor, highly resistant subpopulations due to adaptive formation of disomic chromosomes. Using a mouse model, we assessed the emergence of heteroresistant clones in the brain during fluconazole treatment and found that the occurrence of heteroresistant clones in vivo with chromosomal disomy is strain dependent. Interestingly, emergence of heteroresistant clones in vivo was unrelated to the strain's MIC to fluconazole.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23836187      PMCID: PMC3811407          DOI: 10.1128/AAC.00694-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate.

Authors:  Laura Rodero; Emilia Mellado; A Carolina Rodriguez; Angela Salve; Liliana Guelfand; Pedro Cahn; Manuel Cuenca-Estrella; Graciela Davel; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

2.  Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi.

Authors:  Leah E Cowen; Susan Lindquist
Journal:  Science       Date:  2005-09-30       Impact factor: 47.728

3.  An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1.

Authors:  Anna Selmecki; Maryam Gerami-Nejad; Carsten Paulson; Anja Forche; Judith Berman
Journal:  Mol Microbiol       Date:  2008-03-20       Impact factor: 3.501

4.  Heteroresistance of Cryptococcus gattii to fluconazole.

Authors:  A Varma; K J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

5.  Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.

Authors:  P Mondon; R Petter; G Amalfitano; R Luzzati; E Concia; I Polacheck; K J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

6.  Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.

Authors:  Edward Sionov; Yun C Chang; H Martin Garraffo; Michael A Dolan; Mahmoud A Ghannoum; Kyung J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

7.  Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.

Authors:  Edward Sionov; Hyeseung Lee; Yun C Chang; Kyung J Kwon-Chung
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

8.  Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.

Authors:  Edward Sionov; Yun C Chang; H Martin Garraffo; Kyung J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

9.  Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy.

Authors:  Guangbo Chen; William D Bradford; Chris W Seidel; Rong Li
Journal:  Nature       Date:  2012-01-29       Impact factor: 49.962

10.  Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner.

Authors:  Camile P Semighini; Anna F Averette; John R Perfect; Joseph Heitman
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

  10 in total
  46 in total

Review 1.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

Review 2.  Cryptococcosis diagnosis and treatment: What do we know now.

Authors:  John R Perfect; Tihana Bicanic
Journal:  Fungal Genet Biol       Date:  2014-10-13       Impact factor: 3.495

3.  Large-Scale Chromosomal Changes and Associated Fitness Consequences in Pathogenic Fungi.

Authors:  Anja Forche
Journal:  Curr Fungal Infect Rep       Date:  2014-06-01

Review 4.  Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.

Authors:  Kyung J Kwon-Chung; James A Fraser; Tamara L Doering; Zhou Wang; Guilhem Janbon; Alexander Idnurm; Yong-Sun Bahn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

5.  Update on Antifungal Drug Resistance.

Authors:  David S Perlin; Erika Shor; Yanan Zhao
Journal:  Curr Clin Microbiol Rep       Date:  2015-06-01

6.  Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.

Authors:  Rodrigo de Carvalho Santana; Letícia Aparecida Schiave; Alda Soares Dos Santos Quaglio; Cristiane Masetto de Gaitani; Roberto Martinez
Journal:  Mycopathologia       Date:  2017-06-27       Impact factor: 2.574

7.  Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistance.

Authors:  Sanjoy Paul; Tamara L Doering; W Scott Moye-Rowley
Journal:  Fungal Genet Biol       Date:  2014-11-01       Impact factor: 3.495

Review 8.  Rapid mechanisms for generating genome diversity: whole ploidy shifts, aneuploidy, and loss of heterozygosity.

Authors:  Richard J Bennett; Anja Forche; Judith Berman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-31       Impact factor: 6.915

Review 9.  Cryptococcal therapies and drug targets: the old, the new and the promising.

Authors:  Carolina Coelho; Arturo Casadevall
Journal:  Cell Microbiol       Date:  2016-04-08       Impact factor: 3.715

Review 10.  Drug resistance and tolerance in fungi.

Authors:  Judith Berman; Damian J Krysan
Journal:  Nat Rev Microbiol       Date:  2020-02-11       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.